NCT05662501 is a NA clinical trial of Pleioflow-RF in Elective Cardiac Surgery, sponsored by Pleioflow.

Who is sponsoring NCT05662501?

NCT05662501 is sponsored by Pleioflow.

What drugs are being tested in NCT05662501?

Interventions in NCT05662501: Pleioflow-RF.

What condition does NCT05662501 study?

NCT05662501 studies Elective Cardiac Surgery.

Is NCT05662501 still recruiting?

NCT05662501 is currently status unknown. Last updated 20 February 2024.

Last reviewed 2024-02-20 · How we verify

NCT05662501

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pleiades Safety and Feasibility Study

Status unknown NA Last updated 20 February 2024

What this trial tests

NA trial testing Pleioflow-RF in Elective Cardiac Surgery in 40 participants. Status unknown.

Timeline

10 January 2024

Primary endpoint
30 May 2024

30 September 2024

Quick facts

Lead sponsor	Pleioflow
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	40
Start date	10 January 2024
Primary completion	30 May 2024
Estimated completion	30 September 2024
Sites	1 location across Greece

Drugs / interventions tested

Pleioflow-RF

Conditions studied

Elective Cardiac Surgery — all drugs for Elective Cardiac Surgery →

Sponsor

Pleioflow

Who can join

Adults 18 to 85, any sex, with Elective Cardiac Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The "Pleiades" study is a non randomised, prospective, single center clinical trial that aims to evaluate the safety and the procedural feasibility of an innovative flow assist device (Pleioflow-RF) in adult patients undergoing elective cardiac surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Elective Cardiac Surgery

Currently open trials in the same condition.

NCT06516432 — Parasternal Blockade and Serum Lactate in Cardiac Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05662501 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pleioflow
Last refreshed: 20 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05662501.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing